▶ 調査レポート

短腸症候群（SBS）の世界市場（～2026年）
• 英文タイトル：Global Short Bowel Syndrome (SBS) Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。短腸症候群（SBS）の世界市場（～2026年） / Global Short Bowel Syndrome (SBS) Market Size, Status and Forecast 2020-2026 / MRC2-11QY04600資料のイメージです。• レポートコード：MRC2-11QY04600
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は短腸症候群（SBS）のグローバル市場について調査・分析したレポートです。種類別（経口ルート、親ルート）市場規模、用途別（病院、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別短腸症候群（SBS）の競争状況、市場シェア
・世界の短腸症候群（SBS）市場：種類別市場規模 2015年-2020年（経口ルート、親ルート）
・世界の短腸症候群（SBS）市場：種類別市場規模予測 2021年-2026年（経口ルート、親ルート）
・世界の短腸症候群（SBS）市場：用途別市場規模 2015年-2020年（病院、診療所、小売薬局）
・世界の短腸症候群（SBS）市場：用途別市場規模予測 2021年-2026年（病院、診療所、小売薬局）
・北米の短腸症候群（SBS）市場分析：米国、カナダ
・ヨーロッパの短腸症候群（SBS）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの短腸症候群（SBS）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の短腸症候群（SBS）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの短腸症候群（SBS）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Merck、Takeda、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.

Market Analysis and Insights: Global Short Bowel Syndrome (SBS) Market
The global Short Bowel Syndrome (SBS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Short Bowel Syndrome (SBS) Scope and Market Size
Short Bowel Syndrome (SBS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome (SBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Market segment by Type, the product can be split into
Oral Route
Parental Route
Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Route
1.4.3 Parental Route
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome (SBS) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Short Bowel Syndrome (SBS) Market Perspective (2015-2026)
2.2 Global Short Bowel Syndrome (SBS) Growth Trends by Regions
2.2.1 Short Bowel Syndrome (SBS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Short Bowel Syndrome (SBS) Historic Market Share by Regions (2015-2020)
2.2.3 Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Short Bowel Syndrome (SBS) Market Growth Strategy
2.3.6 Primary Interviews with Key Short Bowel Syndrome (SBS) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome (SBS) Players by Market Size
3.1.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue (2015-2020)
3.1.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Short Bowel Syndrome (SBS) Market Concentration Ratio
3.2.1 Global Short Bowel Syndrome (SBS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Revenue in 2019
3.3 Short Bowel Syndrome (SBS) Key Players Head office and Area Served
3.4 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
3.5 Date of Enter into Short Bowel Syndrome (SBS) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2015-2020)
4.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)
5.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Short Bowel Syndrome (SBS) Market Size (2015-2020)
6.2 Short Bowel Syndrome (SBS) Key Players in North America (2019-2020)
6.3 North America Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
6.4 North America Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Market Size (2015-2020)
7.2 Short Bowel Syndrome (SBS) Key Players in Europe (2019-2020)
7.3 Europe Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
7.4 Europe Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

8 China
8.1 China Short Bowel Syndrome (SBS) Market Size (2015-2020)
8.2 Short Bowel Syndrome (SBS) Key Players in China (2019-2020)
8.3 China Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
8.4 China Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Short Bowel Syndrome (SBS) Market Size (2015-2020)
9.2 Short Bowel Syndrome (SBS) Key Players in Japan (2019-2020)
9.3 Japan Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
9.4 Japan Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Short Bowel Syndrome (SBS) Market Size (2015-2020)
10.2 Short Bowel Syndrome (SBS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
10.4 Southeast Asia Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

11 India
11.1 India Short Bowel Syndrome (SBS) Market Size (2015-2020)
11.2 Short Bowel Syndrome (SBS) Key Players in India (2019-2020)
11.3 India Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
11.4 India Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Short Bowel Syndrome (SBS) Market Size (2015-2020)
12.2 Short Bowel Syndrome (SBS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Short Bowel Syndrome (SBS) Market Size by Type (2015-2020)
12.4 Central & South America Short Bowel Syndrome (SBS) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Short Bowel Syndrome (SBS) Introduction
13.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview
13.2.3 Takeda Short Bowel Syndrome (SBS) Introduction
13.2.4 Takeda Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Emmaus Medical
13.3.1 Emmaus Medical Company Details
13.3.2 Emmaus Medical Business Overview
13.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Introduction
13.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.3.5 Emmaus Medical Recent Development
13.4 Ardelyx
13.4.1 Ardelyx Company Details
13.4.2 Ardelyx Business Overview
13.4.3 Ardelyx Short Bowel Syndrome (SBS) Introduction
13.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.4.5 Ardelyx Recent Development
13.5 Naia Pharmaceuticals
13.5.1 Naia Pharmaceuticals Company Details
13.5.2 Naia Pharmaceuticals Business Overview
13.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
13.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.5.5 Naia Pharmaceuticals Recent Development
13.6 Nutrinia
13.6.1 Nutrinia Company Details
13.6.2 Nutrinia Business Overview
13.6.3 Nutrinia Short Bowel Syndrome (SBS) Introduction
13.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.6.5 Nutrinia Recent Development
13.7 OxThera
13.7.1 OxThera Company Details
13.7.2 OxThera Business Overview
13.7.3 OxThera Short Bowel Syndrome (SBS) Introduction
13.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.7.5 OxThera Recent Development
13.8 Sancilio Pharmaceuticals
13.8.1 Sancilio Pharmaceuticals Company Details
13.8.2 Sancilio Pharmaceuticals Business Overview
13.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
13.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.8.5 Sancilio Pharmaceuticals Recent Development
13.9 Zealand Pharma
13.9.1 Zealand Pharma Company Details
13.9.2 Zealand Pharma Business Overview
13.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Introduction
13.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2015-2020)
13.9.5 Zealand Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Short Bowel Syndrome (SBS) Key Market Segments
Table 2. Key Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
Table 3. Ranking of Global Top Short Bowel Syndrome (SBS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Route
Table 6. Key Players of Parental Route
Table 7. Global Short Bowel Syndrome (SBS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Short Bowel Syndrome (SBS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Short Bowel Syndrome (SBS) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Short Bowel Syndrome (SBS) Market Share by Regions (2015-2020)
Table 11. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Short Bowel Syndrome (SBS) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Short Bowel Syndrome (SBS) Market Growth Strategy
Table 17. Main Points Interviewed from Key Short Bowel Syndrome (SBS) Players
Table 18. Global Short Bowel Syndrome (SBS) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Short Bowel Syndrome (SBS) Market Share by Players (2015-2020)
Table 20. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2019)
Table 21. Global Short Bowel Syndrome (SBS) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Short Bowel Syndrome (SBS) Product Solution and Service
Table 24. Date of Enter into Short Bowel Syndrome (SBS) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Short Bowel Syndrome (SBS) Market Size Share by Type (2015-2020)
Table 28. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2021-2026)
Table 29. Global Short Bowel Syndrome (SBS) Market Size Share by Application (2015-2020)
Table 30. Global Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Short Bowel Syndrome (SBS) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 34. North America Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 36. North America Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 38. Europe Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 40. Europe Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 42. Europe Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 44. China Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 46. China Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 47. China Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 48. China Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 49. China Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 50. Japan Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 52. Japan Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 54. Japan Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 58. Southeast Asia Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 60. Southeast Asia Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 62. India Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 64. India Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 65. India Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 66. India Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 67. India Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Short Bowel Syndrome (SBS) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Short Bowel Syndrome (SBS) Market Share (2019-2020)
Table 70. Central & South America Short Bowel Syndrome (SBS) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Short Bowel Syndrome (SBS) Market Share by Type (2015-2020)
Table 72. Central & South America Short Bowel Syndrome (SBS) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Short Bowel Syndrome (SBS) Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Takeda Company Details
Table 80. Takeda Business Overview
Table 81. Takeda Product
Table 82. Takeda Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 83. Takeda Recent Development
Table 84. Emmaus Medical Company Details
Table 85. Emmaus Medical Business Overview
Table 86. Emmaus Medical Product
Table 87. Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 88. Emmaus Medical Recent Development
Table 89. Ardelyx Company Details
Table 90. Ardelyx Business Overview
Table 91. Ardelyx Product
Table 92. Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 93. Ardelyx Recent Development
Table 94. Naia Pharmaceuticals Company Details
Table 95. Naia Pharmaceuticals Business Overview
Table 96. Naia Pharmaceuticals Product
Table 97. Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 98. Naia Pharmaceuticals Recent Development
Table 99. Nutrinia Company Details
Table 100. Nutrinia Business Overview
Table 101. Nutrinia Product
Table 102. Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 103. Nutrinia Recent Development
Table 104. OxThera Company Details
Table 105. OxThera Business Overview
Table 106. OxThera Product
Table 107. OxThera Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 108. OxThera Recent Development
Table 109. Sancilio Pharmaceuticals Business Overview
Table 110. Sancilio Pharmaceuticals Product
Table 111. Sancilio Pharmaceuticals Company Details
Table 112. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 113. Sancilio Pharmaceuticals Recent Development
Table 114. Zealand Pharma Company Details
Table 115. Zealand Pharma Business Overview
Table 116. Zealand Pharma Product
Table 117. Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2015-2020) (Million US$)
Table 118. Zealand Pharma Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome (SBS) Market Share by Type: 2020 VS 2026
Figure 2. Oral Route Features
Figure 3. Parental Route Features
Figure 4. Global Short Bowel Syndrome (SBS) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Short Bowel Syndrome (SBS) Report Years Considered
Figure 9. Global Short Bowel Syndrome (SBS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Short Bowel Syndrome (SBS) Market Share by Regions: 2020 VS 2026
Figure 11. Global Short Bowel Syndrome (SBS) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Short Bowel Syndrome (SBS) Market Share by Players in 2019
Figure 14. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Revenue in 2019
Figure 16. North America Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Short Bowel Syndrome (SBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介
  • 短腸症候群（SBS）治療薬の世界市場（～2026年）
    Global Short Bowel Syndrome (SBS) Drugs Market Insights and Forecast to 2026
    MRC2-11QY09456 2020年11月25日 112Pages
    当調査資料は短腸症候群（SBS）治療薬のグローバル市場について調査・分析したレポートです。種類別（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...
  • 短腸症候群の世界市場（～2026年）
    Global Short Bowel Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY04601 2020年11月20日 93Pages
    当調査資料は短腸症候群のグローバル市場について調査・分析したレポートです。種類別（GLP-2、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...
  • 炎症性腸疾患（IBD）の世界市場（～2026年）
    Global Inflammatory Bowel Disease Market Size, Status and Forecast 2020-2026
    MRC2-11QY12376 2020年11月25日 98Pages
    当調査資料は炎症性腸疾患（IBD）のグローバル市場について調査・分析したレポートです。種類別（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物学的薬剤）、免疫調節剤）市場規模、用途別（治療、診断）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...
  • 急性冠症候群（ACS）の世界市場（～2026年）
    Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2020-2026
    MRC2-11QY13561 2020年11月30日 92Pages
    当調査資料は急性冠症候群（ACS）のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...
  • ドラベ症候群治療薬の世界市場（～2026年）
    Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY11710 2020年11月25日 98Pages
    当調査資料はドラベ症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...
  • 脆弱X症候群の世界市場（～2026年）
    Global Fragile X Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY11990 2020年11月25日 95Pages
    当調査資料は脆弱X症候群のグローバル市場について調査・分析したレポートです。種類別（ACT-01、AMO-01、ANAVEX-273、AUT-00206、ブリオスタチン-1、カンナビジオール、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...
  • 吸収不良症候群の世界市場（～2026年）
    Global Malabsorption Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY12575 2020年11月25日 93Pages
    当調査資料は吸収不良症候群のグローバル市場について調査・分析したレポートです。種類別（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害）市場規模、用途別（製薬会社、病院、栄養クリニック、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • ドラベ症候群治療の世界市場（～2026年）
    Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11711 2020年11月25日 97Pages
    当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • チャーグ・ストラウス症候群の世界市場（～2026年）
    Global Churg Strauss Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY11375 2020年11月25日 95Pages
    当調査資料はチャーグ・ストラウス症候群のグローバル市場について調査・分析したレポートです。種類別（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）市場規模、用途別（研究所、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...
  • パリーロンバーグ病の世界市場（～2026年）
    Global Parry-Romberg Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY04167 2020年11月20日 96Pages
    当調査資料はパリーロンバーグ病のグローバル市場について調査・分析したレポートです。種類別（健康診断、MRIスキャン、血清検査）市場規模、用途別（病院＆クリニック、理学療法士）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...
  • 短腸症候群の世界市場（～2026年）短腸症候群の世界市場（～2026年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…
  • 短腸症候群（SBS）治療薬の世界市場（～2026年）短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
  • 炎症性腸疾患（IBD）治療の世界市場（～2026年）炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
  • 炎症性腸疾患（IBD）の世界市場（～2026年）炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
  • 腸管理システムの世界市場（～2026年）腸管理システムの世界市場（～2026年） Bowel management is the process which a person with a bowel disability uses to manage fecal incontinence or constipation. People who have a medical condition which impairs control of their defecation use bowel management techniques to choose a predictable time and place to evacuate. A simple bowel m…